The Scandinavian Sarcoma Group

Prognostic factors and follow‐up strategy for superficial soft‐tissue sarcomas: Analysis of 622 surgically treated patients from the scandinavian sarcoma group register

“…Our study, based on prospectively collected data from the Scandinavian Sarcoma Group (SSG) Register, includes the largest number of SSTS patients thus far. The SSG database is considered representative of the entire population, and is a homogeneous registry in terms of classification of variables, reporting routines and treatment guidelines . This minimizes the inherent drawbacks of registry studies.…”

“…Two independent studies have reported a 3 cm median tumor size for SSTS . Taking into account that deep‐seated tumors are considerably larger, STS in general having a median size of approximately 8 cm , it appears that SSTS, being easily detectable, are diagnosed and treated earlier. Still, the vast majority of the tumors were high grade malignancies, a fact that corroborates previously published data , and is comparable to series where deep‐seated STS dominate .…”

“…However, we advocate wide resection, that is at least 1 cm margin in the surrounding soft tissue, as this is as a rule accompanied by a low morbidity in the case of superficial tumors and obviates the need for adjuvant radiotherapy. Thus, radiotherapy appears not to have a routine role in the treatment of SSTS, in contrast to deep‐seated STS . Yet, it may be offered to selected patients, that is in the case of high‐grade tumors that are excised with a marginal margin.…”

Anterior Approach in a Huge Lipomatous Tumor of the Thigh

“…Lipomas and liposarcomas are tumors of mesenchymal origin with adipose cells. Liposarcomas include 10–16% of all soft tissue sarcomas [ 4 ] and include five subtypes with different morphological, cytogenetic, and clinical features. One of them is atypical lipomatous tumor or well-differentiated liposarcoma.…”

Tactique diagnostique lors de la prise en charge des tumeurs osseuses

“…La prise en charge de cette tumeur doit impérativement suivre des règles strictes sous peine de compromettre le pronostic vital. Démon-trant cette nécessité, les registres scandinaves ont permis d'établir que la prise en charge dans un centre de réfé-rence améliorait le pronostic [1]. Ces centres de références, actuellement officiellement prônés par l'Institut national du cancer (Inca) au niveau régional ou inter-régional doivent permettre une prise en charge multidisciplinaire (anatomopathologistes, chirurgiens, oncologues, radiologues et radiothérapeutes) et une organisation en réseaux (éventuel-lement nationaux).…”